Pharmagen Stock Buy Hold or Sell Recommendation
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Pharmagen is 'Strong Sell'. A buy or sell recommendation is an automated directive regarding whether to purchase or sell Pharmagen given historical horizon and risk tolerance. When we issue a 'buy' or 'sell' recommendation for Pharmagen, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Pharmagen Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more information on how to buy Pharmagen Stock please use our How to Invest in Pharmagen guide. In addition, we conduct extensive research on individual companies such as Pharmagen and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Pharmagen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
Pharmagen |
Execute Pharmagen Buy or Sell Advice
The Pharmagen recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Pharmagen. Macroaxis does not own or have any residual interests in Pharmagen or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Pharmagen's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Not Rated
Pharmagen Trading Alerts and Improvement Suggestions
| Pharmagen generated a negative expected return over the last 90 days | |
| Pharmagen has high historical volatility and very poor performance | |
| Pharmagen has some characteristics of a very speculative penny stock | |
| Pharmagen has a very high chance of going through financial distress in the upcoming years | |
| Pharmagen currently holds 2.16 M in liabilities. Pharmagen has a current ratio of 0.1, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Pharmagen's use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the previous year's revenue of 4.81 M. Net Loss for the year was (6 M) with profit before overhead, payroll, taxes, and interest of 2.75 M. | |
| Pharmagen currently holds about 264.67 K in cash with (692.07 K) of positive cash flow from operations. | |
| Pharmagen has a frail financial position based on the latest SEC disclosures |
Pharmagen Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Pharmagen or Health Care Providers & Services sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Pharmagen's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Pharmagen stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.00 | |
β | Beta against Dow Jones | 0.00 | |
σ | Overall volatility | 12.91 | |
Ir | Information ratio | 0.00 |
Pharmagen Volatility Alert
At this time Pharmagen exhibits very low volatility. You can indeed make money on Pharmagen instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Pharmagen Fundamentals Vs Peers
Comparing Pharmagen's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Pharmagen's direct or indirect competition across all of the common fundamentals between Pharmagen and the related equities. This way, we can detect undervalued stocks with similar characteristics as Pharmagen or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Pharmagen's fundamental indicators could also be used in its relative valuation, which is a method of valuing Pharmagen by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Pharmagen to competition |
| Fundamentals | Pharmagen | Peer Average |
| Return On Asset | -0.59 | -0.14 |
| Profit Margin | (1.33) % | (1.27) % |
| Operating Margin | (0.31) % | (5.51) % |
| Current Valuation | 5.93 M | 16.62 B |
| Shares Outstanding | 517.08 M | 571.82 M |
| Price To Earning | (0.06) X | 28.72 X |
| Price To Sales | 0.08 X | 11.42 X |
| Revenue | 4.81 M | 9.43 B |
| Gross Profit | 2.75 M | 27.38 B |
| EBITDA | (2.13 M) | 3.9 B |
| Net Income | (6 M) | 570.98 M |
| Cash And Equivalents | 264.67 K | 2.7 B |
| Total Debt | 2.16 M | 5.32 B |
| Current Ratio | 0.10 X | 2.16 X |
| Book Value Per Share | (0.02) X | 1.93 K |
| Cash Flow From Operations | (692.07 K) | 971.22 M |
| Target Price | 0.13 | |
| Number Of Employees | 24 | 18.84 K |
| Beta | 0.028 | -0.15 |
| Market Capitalization | 361.95 K | 19.03 B |
| Total Asset | 1.28 M | 29.47 B |
| Working Capital | (7.46 M) | 1.48 B |
| Current Asset | 837 K | 9.34 B |
| Current Liabilities | 8.29 M | 7.9 B |
| Net Asset | 1.28 M |
About Pharmagen Buy or Sell Advice
When is the right time to buy or sell Pharmagen? Buying financial instruments such as Pharmagen Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Pharmagen in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Gold ETFs Thematic Idea Now
Gold ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Gold ETFs theme has 20 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Gold ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Pharmagen Stock Analysis
When running Pharmagen's price analysis, check to measure Pharmagen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharmagen is operating at the current time. Most of Pharmagen's value examination focuses on studying past and present price action to predict the probability of Pharmagen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharmagen's price. Additionally, you may evaluate how the addition of Pharmagen to your portfolios can decrease your overall portfolio volatility.